Skip to main content
    C

    Collplant Biotechnologies Ltd (CLGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.64
    -0.02 (-0.43%)

    Market Cap: $14.27M

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Collplant Biotechnologies Ltd (CLGN) Valuation Multiples

    Updated Nov 13, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Collplant Biotechnologies (CLGN) trades at 21.0x sales and 2.3x book value. Its forward P/E is 80.0x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E80.0x
    Price to sales21.0x
    Price to book2.3x
    PEGN/A
    FCF yield-174.8%

    As of Nov 13, 2026

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLGN

    What is CLGN's forward P/E ratio?

    Collplant Biotechnologies has a forward P/E ratio of 80.0x.

    Is CLGN stock overvalued?

    GNG's valuation label for CLGN is Fairly valued.

    What is CLGN's price to sales ratio?

    Collplant Biotechnologies has a price to sales ratio of 21.0x.